Farydak: Clinical Trials

6 trials of Farydak, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 3 terminated. 6 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 16Completed 3, Terminated 3
Phase 22Completed 2

Follow Farydak: new trials by email Literature Review of Farydak trials Research Report on Farydak

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Panobinostat in Combination With Daratumumab, Bortezomib and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma
Bortezomib, Daratumumab and Hyaluronidase-fihj, Dexamethasone - Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma
Phase 1TerminatedAbdullah Khan12021-09-272024-06-06
Non-Invasive Focused Ultrasound (FUS) With Oral Panobinostat in Children With Progressive Diffuse Midline Glioma (DMG)
Panobinostat 15 MG, Focused Ultrasound with neuro-navigator-controlled sonication - Diffuse Intrinsic Pontine Glioma, Diffuse Pontine and Thalamic Gliomas
Phase 1TerminatedColumbia University52021-07-282025-06-08
Phase I Study of Marizomib + Panobinostat for Children With DIPG
Marizomib, Panobinostat - Diffuse Intrinsic Pontine Glioma, Pediatric Brainstem Glioma
Phase 1TerminatedDana-Farber Cancer Institute42020-08-102024-02-15
Reducing the Residual Reservoir of HIV-1 Infected Cells in Patients Receiving Antiretroviral Therapy
Panobinostat, Pegylated Interferon-alpha2a - HIV Infection
Phase 1 / Phase 2CompletedMassachusetts General Hospital172016-05-012024-02-28
Panobinostat and Carfilzomib in Treating Participants With Relapsed or Refractory Multiple Myeloma
Carfilzomib, Panobinostat - Non-Secretory Plasma Cell Myeloma, Plasmacytosis
Phase 1CompletedM.D. Anderson Cancer Center632011-07-282023-09-29
LBH589 and Bevacizumab in Patients With Recurrent High Grade Glioma
LBH589, bevacizumab - Malignant Glioma
Phase 1 / Phase 2CompletedPatrick Y. Wen, MD512009-03-012017-03-14

Conditions studied

Diffuse Intrinsic Pontine Glioma (2)  ·  Multiple Myeloma (2)  ·  Glioma (1)  ·  HIV Infections (1)  ·  Neoplasms (1)  ·  Recurrence (1)

Sponsors

Abdullah Khan (1)  ·  Columbia University (1)  ·  Dana-Farber Cancer Institute (1)  ·  M.D. Anderson Cancer Center (1)  ·  Massachusetts General Hospital (1)  ·  Patrick Y. Wen, MD (1)

Countries

United States (6)

Top investigators

Abdullah M Khan, MBBS, MSc (1)  ·  Cheng-Chia Wu, MD, PhD (1)  ·  Daniel R Kuritzkes, MD (1)  ·  Katherine Warren, MD (1)  ·  Mathias Lichterfeld, MD, PhD (1)  ·  Patrick Y. Wen, MD (1)  ·  Rajesh T Gandhi, MD (1)  ·  Robert Orlowski (1)

Results publications

PMID 21984064, PMID 25572329

NIH funding

P30CA016672 (1)